These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7282677)

  • 1. Restricted cephalosporin use in teaching hospitals.
    Johnson PN; Jeffrey LP
    Am J Hosp Pharm; 1981 Apr; 38(4):513-7. PubMed ID: 7282677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cephalosporin-use restrictions in teaching hospitals.
    McCloskey WW; Johnson PN; Jeffrey LP
    Am J Hosp Pharm; 1984 Nov; 41(11):2359-62. PubMed ID: 6507437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic restriction in hospitals associated with medical schools.
    Klapp DL; Ramphal R
    Am J Hosp Pharm; 1983 Nov; 40(11):1957-60. PubMed ID: 6650526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods of controlling cephalosporin use in Canadian hospitals.
    Godin JP; Sketris IS; Merrett RA; Marrie TJ
    Can J Hosp Pharm; 1988 Apr; 41(2):73-4, 83-4, 96. PubMed ID: 10287052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
    Cramer R; Wright C
    Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost containment through restriction of cephalosporins.
    Britton HL; Schwinghammer TL; Romano MJ
    Am J Hosp Pharm; 1981 Dec; 38(12):1897-900. PubMed ID: 7325168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of formulary system policies and procedures.
    Rascati KL
    Am J Hosp Pharm; 1992 Jan; 49(1):100-3. PubMed ID: 1570847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost savings achieved through cephalosporin use review and restriction.
    Dzierba SH; Reilly RT; Caselnova DA
    Am J Hosp Pharm; 1986 Sep; 43(9):2194-7. PubMed ID: 3766571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Savings achieved through cephalosporin surveillance.
    Katz E; Schlamowitz S
    Am J Hosp Pharm; 1978 Dec; 35(12):1521-3. PubMed ID: 717407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion of innovation II: Formulary acceptance rates of new drugs in teaching and non-teaching British Columbia hospitals--a drug development perspective.
    D'Sa MM; Hill DS; Stratton TP
    Can J Hosp Pharm; 1995 Feb; 48(1):7-15. PubMed ID: 10141063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influencing drug use through prescribing restrictions.
    Huber SL; Patry RA; Hudson HD
    Am J Hosp Pharm; 1982 Nov; 39(11):1898-901. PubMed ID: 6128922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eliminating analgesic meperidine use with a supported formulary restriction.
    O'Connor AB; Lang VJ; Quill TE
    Am J Med; 2005 Aug; 118(8):885-9. PubMed ID: 16084182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital formularies: organizational aspects and supplementary components.
    Rucker TD; Visconti JA
    Am J Hosp Pharm; 1976 Sep; 33(9):912-7. PubMed ID: 984056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the British Columbia reference drug program on hospital formularies: a survey of hospital pharmacy managers.
    Gill NJ; Frighetto L; Marra C; Jewesson P
    Can J Clin Pharmacol; 2000; 7(2):109-14. PubMed ID: 10958707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug usage review of cefamandole at a teaching hospital.
    Zaremba CD; Bachand RL; Chow AW; Jewesson PJ
    Can J Hosp Pharm; 1988 Aug; 41(4):195-99, 214. PubMed ID: 10288851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing outpatient costs of nonsteroidal antiinflammatory drugs at a Department of Veterans Affairs teaching hospital.
    Drexler PG; Lambdin CS
    J Pharm Technol; 1993; 9(1):10-3. PubMed ID: 10123760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion of innovation I: Formulary acceptance rates of new drugs in teaching and non-teaching British Columbia hospitals--a hospital pharmacy perspective.
    D'Sa MM; Hill DS; Stratton TP
    Can J Hosp Pharm; 1994 Dec; 47(6):254-60. PubMed ID: 10139270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversies in antimicrobial therapy: formulary decisions on third-generation cephalosporins.
    Barriere SL
    Am J Hosp Pharm; 1986 Mar; 43(3):625-9. PubMed ID: 3706317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hospital formularies on fluoroquinolone prescribing in emergency departments.
    Aspinall SL; Metlay JP; Maselli JH; Gonzales R
    Am J Manag Care; 2007 May; 13(5):241-8. PubMed ID: 17488189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ohio hospital formularies: an analysis of structure, process, and outcome.
    Parrish RH; Berger BA
    Hosp Pharm; 1985 Aug; 20(8):600-3, 606-11. PubMed ID: 10289647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.